Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
Back
EBCL-0030
DILI (Drug-Induced Liver Injury) is liver damage or injury caused by the use of pharmaceutical drugs or medications. DILI can manifest in various forms, ranging from mild elevations in liver enzymes to severe liver failure. The severity of DILI can vary widely from person to person and depends on the individual's genetics and health, and the drug involved. Healthcare providers and researchers closely monitor the capability of drugs to cause DILI, and regulatory agencies have established guidelines for assessing and mitigating this risk during drug development. Understanding and managing DILI is crucial to ensuring the safety of pharmaceuticals and protecting patients from harm.
The Library of Most-DILI-Concern Drugs comprises a selection of pharmaceutical compounds known for their potential to induce liver injury in patients. These drugs have been extensively studied and documented for their hepatotoxic effects. Researchers and healthcare professionals can use this library for in-depth investigations into DILI mechanisms, risk factors, and possible mitigation strategies. It serves as a valuable resource for advancing our understanding of liver-related adverse drug reactions and improving drug safety profiles.
Related terms: H1 receptor, D2 receptor, carbonic anhydrase, acetylcholinesterase, COX-1, epidermal growth factor receptor, D3 receptor.
Mechanism of drug-induced liver injury (Created by BioRender.com)
Ketoconazole is an anti-fungal agent, a CYP3A4 and CYP24A1 inhibitor.
Zafirlukast is a leukotriene receptor antagonist used for treatment of asthma.
Tipranavir is a protease inhibitor used to treat HIV-1.
Ritonavir is an inhibitor of HIV protease and Cytochrome P450, used to treat HIV infection and AIDS.
We propose the complete list of Services powered by Enamine
All our products are for research purpose only. Any personal or non-scientific use is strictly prohibited.
NoteAll the compounds with solubility below 10 mM are shipped as 2 mM solutions.
A set of 71 bioactive molecules for HTS/HCS programs.
The library is composed of drugs that are the most potential for causing drug-induced liver injury.
Most-DILI-Concern Drugs Library covers only approved drugs.
Calculated structural diversity of the collection: 0.89.
Comprehensive documentation with structures, trivial names, synonyms, activity coefficient values, types of action on target and references to original literature.
NMR and LCMS validated purity.
All the compounds are available in stock for hit follow-up.
The library is continuously updated.
Wnt signaling pathway
9
9
Number of compounds
9
Steroid hormone receptors
6
6
Number of compounds
6
G protein-coupled receptors
6
6
Number of compounds
6
Receptor tyrosine kinases (RTKs)
6
6
Number of compounds
6
Potassium channels
5
5
Number of compounds
5
© 2026 Copyright Enamine